drugset / Trial / NCT00409526
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
NaSingle-groupOpen-labelTreatment
Summary
Inhaled Iloprost will be administered to near term infants with Persistent Pulmonary Hypertension of the Newborn in two different doses in order to test safety and efficacy in reducing pulmonary artery pressure.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-12
- Completion
- 2007-12
Outcome
Outcome not reported
Stopped: “Sub-Investigator left U of C”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloprost | Other / unclassified | 50 ug | Inhaled |
| Subject | Iloprost | Other / unclassified | 100 ug | Inhaled |